Skip to main content

Michael Ulz

Stock Analyst at Morgan Stanley

Total Price Targets
17
Stocks Covered
10
Sectors
Healthcare
Most Recent
Feb 25, 2026

Notable Calls (Last 12 Months)

Most Bullish

  • VIR+223.0%
    Vir Biotechnology, Inc.
    $24.00 targetFeb 24, 2026
  • KYTX+220.9%
    Kyverna Therapeutics, Inc.
    $25.00 targetDec 4, 2025
  • VKTX+218.6%
    Viking Therapeutics, Inc.
    $99.00 targetFeb 12, 2026

Most Bearish

  • ALNY+4.1%
    Alnylam Pharmaceuticals, Inc.
    $475.00 targetOct 6, 2025
  • RYTM+6.7%
    Rhythm Pharmaceuticals, Inc.
    $95.00 targetJul 9, 2025
  • ALNY+10.1%
    Alnylam Pharmaceuticals, Inc.
    $495.00 targetOct 30, 2025

Stocks Covered by Michael Ulz

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
IONSIonis Pharmaceuticals, Inc.$95.00$75.86+25.2%2Feb 25, 2026
VIRVir Biotechnology, Inc.$24.00$10.02+139.6%3Feb 24, 2026
VKTXViking Therapeutics, Inc.$99.00$29.80+232.2%2Feb 12, 2026
KYTXKyverna Therapeutics, Inc.$33.00$8.84+273.3%2Dec 15, 2025
MIRMMirum Pharmaceuticals, Inc.$95.00$97.47-2.5%1Dec 9, 2025
ALNYAlnylam Pharmaceuticals, Inc.$495.00$297.62+66.3%2Oct 30, 2025
RYTMRhythm Pharmaceuticals, Inc.$95.00$82.41+15.3%1Jul 9, 2025
DYNDyne Therapeutics, Inc.$52.00$17.50+197.1%2Aug 14, 2024
CABACabaletta Bio, Inc.$3.00$2.94+1.9%1Aug 30, 2022
IOVAIovance Biotherapeutics, Inc.$12.50$3.40+267.1%1Aug 23, 2022

Recent Activity

  • Feb 25, 2026— Set$95.00price target onIONS(Ionis Pharmaceuticals, Inc.)
  • Feb 24, 2026— Set$24.00price target onVIR(Vir Biotechnology, Inc.)
  • Feb 12, 2026— Set$99.00price target onVKTX(Viking Therapeutics, Inc.)
  • Dec 15, 2025— Set$33.00price target onKYTX(Kyverna Therapeutics, Inc.)
  • Dec 9, 2025— Set$95.00price target onMIRM(Mirum Pharmaceuticals, Inc.)
  • Dec 4, 2025— Set$25.00price target onKYTX(Kyverna Therapeutics, Inc.)
  • Oct 30, 2025— Set$495.00price target onALNY(Alnylam Pharmaceuticals, Inc.)
  • Oct 6, 2025— Set$475.00price target onALNY(Alnylam Pharmaceuticals, Inc.)
  • Sep 2, 2025— Set$71.00price target onIONS(Ionis Pharmaceuticals, Inc.)
  • Jul 9, 2025— Set$95.00price target onRYTM(Rhythm Pharmaceuticals, Inc.)
  • Jan 9, 2025— Set$20.00price target onVIR(Vir Biotechnology, Inc.)
  • Aug 14, 2024— Set$52.00price target onDYN(Dyne Therapeutics, Inc.)
  • Jun 27, 2024— Set$105.00price target onVKTX(Viking Therapeutics, Inc.)
  • Jun 5, 2024— Set$15.00price target onVIR(Vir Biotechnology, Inc.)
  • Apr 30, 2024— Set$40.00price target onDYN(Dyne Therapeutics, Inc.)
  • Aug 30, 2022— Set$3.00price target onCABA(Cabaletta Bio, Inc.)
  • Aug 23, 2022— Set$12.50price target onIOVA(Iovance Biotherapeutics, Inc.)

Frequently Asked Questions

Who is Michael Ulz?

Michael Ulz is a stock analyst at Morgan Stanley covering 10 stocks primarily in Healthcare. They have issued 17 price targets since Aug 23, 2022.

What stocks does Michael Ulz cover?

Michael Ulz currently covers 10 stocks, including VIR, IONS, VKTX, KYTX, ALNY.

What is Michael Ulz's latest price target?

Michael Ulz's most recent price target was $95.00 on IONS (Ionis Pharmaceuticals, Inc.), set on Feb 25, 2026.

What is Michael Ulz's highest price target?

Michael Ulz's highest issued price target is $495.00 on ALNY, set on Oct 30, 2025.

Coverage based on publicly published price targets. Not investment advice.